Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional database.
作者： Zachariah Allen , Gregory S. Merrick , Peter Grimm , John Blasko , John Sylvester
DOI: 10.1016/J.MEDDOS.2007.09.001
关键词:
摘要: vs. 89.3% and 102.3% for Pro-Qura community plans, respectively. When analyzed in terms of the first 8 sequence groups (10 patients/sequence group) each institution, planning resulted less postimplant variability V100 (86.2– 89.5%) D90 (97.4 –103.2%) while community-generated plans had greater (85.3–91.2%) (95.9 –105.2%) ranges. In groups, dosimetry was deemed “too cool” 11% to 30% cases hot” 12% 27%. On average, no clinically significant dosimetric differences were discerned between community-based planning. However, substantially identified plan cohort. It is possible that and/or routine evaluation may have influenced outcomes at centers. © 2008 American Association Medical Dosimetrists.
elsevier.com
sci-hub.se 参考文章(16)
GREGORY S. MERRICK, KENT E. WALLNER, WAYNE M. BUTLER, Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. The Journal of Urology. ,vol. 169, pp. 1643- 1652 ,(2003) , 10.1097/01.JU.0000035544.25483.61
Marisa A Kollmeier, Richard G Stock, Nelson Stone, Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality International Journal of Radiation Oncology Biology Physics. ,vol. 57, pp. 645- 653 ,(2003) , 10.1016/S0360-3016(03)00627-8
W.Robert Lee, Allan F deGuzman, Rick L Bare, Mark G Marshall, David L McCullough, Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. International Journal of Radiation Oncology Biology Physics. ,vol. 46, pp. 83- 88 ,(2000) , 10.1016/S0360-3016(99)00359-4
Gregory S Merrick, Kent E Wallner, Wayne M Butler, Minimizing prostate brachytherapy-related morbidity☆ Urology. ,vol. 62, pp. 786- 792 ,(2003) , 10.1016/S0090-4295(03)00558-2
Jeanette Blauth, Scot Fisher, David Henry, Franco Nichini, The role of splenic irradiation in treating HIV-associated immune thrombocytopenia International Journal of Radiation Oncology Biology Physics. ,vol. 45, pp. 457- 460 ,(1999) , 10.1016/S0360-3016(99)00181-9
Lee K McNeely, Nelson N Stone, Joseph Presser, Jeffrey H Chircus, Richard G Stock, Influence of prostate volume on dosimetry results in real-time 125I seed implantation. International Journal of Radiation Oncology Biology Physics. ,vol. 58, pp. 292- 299 ,(2004) , 10.1016/S0360-3016(03)00783-1
William S. Bice, Bradley R. Prestidge, Peter D. Grimm, Jay L. Friedland, Vladimir Feygelman, Mack Roach, James J. Prete, Donald F. Dubois, John C. Blasko, Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 41, pp. 921- 927 ,(1998) , 10.1016/S0360-3016(98)90123-7
Mark J. Rivard, Wayne M. Butler, Phillip M. Devlin, John K. Hayes, Robert A. Hearn, Eugene P. Lief, Ali S. Meigooni, Gregory S. Merrick, Jeffrey F. Williamson, American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy. ,vol. 6, pp. 34- 37 ,(2007) , 10.1016/J.BRACHY.2006.11.001
R STOCK, N STONE, A TABERT, C IANNUZZI, J DEWYNGAERT, A dose-response study for I-125 prostate implants International Journal of Radiation Oncology Biology Physics. ,vol. 41, pp. 101- 108 ,(1998) , 10.1016/S0360-3016(98)00006-6
W.Robert Lee, Mack Roach, Jeff Michalski, Brian Moran, David Beyer, Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. International Journal of Radiation Oncology Biology Physics. ,vol. 54, pp. 457- 461 ,(2002) , 10.1016/S0360-3016(02)02950-4